Protalix BioTherapeutics (PLX) EBIT (2010 - 2026)
Protalix BioTherapeutics' EBIT came in at $4.67 million for Q2 2026, up 298.6% from $1.17 million a year earlier but down 77.9% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EBIT (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Protalix BioTherapeutics reported EBIT of $23.29 million, up 183.1% year-over-year; for FY2025, it was -$5.5 million.
- Going back by year, EBIT was $3.92 million in FY2024 (-62.6%), $10.46 million in FY2023, -$13.01 million in FY2022 and -$20.46 million in FY2021.
- The five-year range for quarterly EBIT is -$5.71 million (Q4 2021) to $21.15 million (Q1 2026).
- Business Quant data shows PLX's EBIT at $21.15 million (Q1 2026), -$4.66 million (Q4 2025) and $2.13 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn | 4.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.67 Mn |
| Mar 31, 2026 | 21.15 Mn |
| Dec 31, 2025 | -4.66 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | -4.15 Mn |
| Dec 31, 2024 | 7.21 Mn |
| Sep 30, 2024 | 3.99 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | -4.86 Mn |
| Dec 31, 2023 | -5.62 Mn |
| Sep 30, 2023 | -1.89 Mn |
| Jun 30, 2023 | 20.42 Mn |
| Mar 31, 2023 | -2.46 Mn |
| Dec 31, 2022 | -2.50 Mn |
| Sep 30, 2022 | -3.13 Mn |
| Jun 30, 2022 | -5.52 Mn |
| Mar 31, 2022 | -1.87 Mn |
| Dec 31, 2021 | -5.71 Mn |
| Sep 30, 2021 | -1.89 Mn |
API Access
Protalix BioTherapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();